Thyro-Tabs (Levothyroxine Sodium)

Warnings

In humans and rodents, excess in utero exposure to thyroid hormones is associated with hypothalamic-pituitary-thyroid axis dysfunction and morphological thyroid gland defects in the offspring. The safety of Thyro-Tabs Canine has not been evaluated in breeding, pregnant, or lactating dogs.

Precautions

Dogs with underlying cardiac disease that are diagnosed with hypothyroidism should be closely monitored during the dose establishment phase. Adjustment of cardiac medication or levothyroxine sodium dosage may be needed depending on clinical response.

Food and Drug Interactions

Human Warnings

Not for use in humans. Keep out of reach of children. In the event of accidental ingestion, seek medical advice immediately and show the product label to the physician. Wash hands after handling.

Possible Side Effects

In a 6-month US field study with the most commonly reported adverse reactions of dogs included: anorexia, dermatitis, vomiting, otitis externa, lethargy, polydipsia, diarrhea, leukocytosis, pruritus, tachypnea, polyuria, hyperactivity, and seborrhea.

Contact your veterinarian if you believe your pet is experiencing side effects.

Product Administration

Oral

Product Form

Tablet

Ingredients

levothyroxine

Storage

Store at controlled room temperature 20°-25°C (68°-77°F) with excursions allowed between 15° and 30°C (59° and 86°F). Protect from light and moisture

Manufacturer

Vetone

Prescribing Info/Brochures

• http://vetone.net/Default/GetFile?id=06489434-17b9-4d36-9faa-28995311dff7